HOME CAREERS CONTACT US KOREAN ENGLISH

General Meeting of Stockholders

  1. HOME
  2. INVESTORS
  3. General Meeting of Stockholders

8th General Meeting of Stockholders of NeoImmuneTech

1. Date : 10:00 AM. Mar 31, 2022
2. Place : B1, Main conference room, Pangyo Innovalley C, 253 Pangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, Republic of Korea
3. Reporting Category
(1) Auditor’s Report
(2) Business Report

4. Agenda
  • Agenda 1 : Approval of the Financial Statements for the Financial Year 2021
  • Agenda 2 : Reappointment of Directors
  • Agenda 2-1 : Reappointment of Standing Director
  • Agenda 2-2 : Reappointment of Outside Director
  • Agenda 3 : Approval of Limit on Remuneration of Directors (USD 5,000,000)
  • Agenda 4 : Approval of Limit on Remuneration of Statutory Auditor (USD 100,000)
  • Agenda 5 : Approval of the grant of stock options pursuant to the Board of Directors’ resolution on September 28, 2021
  • Agenda 6 : Grant of Stock Options
reference material
Results of the 8th general meeting of shareholders

(Share present : 9,914,326 / 19,716,402 (50.28%))

Agenda Result
Agenda 1 Approval of the Financial Statements for the Financial Year 2021 Approved
Agenda 2

Agenda 2-1
Agenda 2-2 		Reappointment of Directors

Reappointment of Standing Director
Reappointment of Outside Director

Approved
Approved
Agenda 3 Approval of Limit on Remuneration of Directors (USD 5,000,000) Approved
Agenda 4 Approval of Limit on Remuneration of Statutory Auditor (USD 100,000) Approved
Agenda 5 Approval of the grant of stock options pursuant to the Board of Directors’ resolution on September 28, 2021 Approved
Agenda 6 Grant of Stock Options Approved

※ Shares present : Total number of the common shares with voting rights represented at the opening of the Meeting basis

7th General Meeting of Stockholders of NeoImmuneTech

1. Date : 10:00 AM. Mar 31, 2021 (KST)
2. Place : 6F, 26, Yeongdong-daero 96-gil, Gangnam-gu, Seoul, Republic of Korea
3. Agenda
  • Agenda 1 : Approval of the Financial Statements for the Financial Year 2020
  • Agenda 2 : Appointment of Directors
  • Agenda 2-1 : Reappointment of Independent Director: Byoung Jo Kang
  • Agenda 2-2 : Appointment of Independent Director: Jin-Hyoung Kang
  • Agenda 2-3 : Appointment of Non-Executive Director: Jung Won Woo
  • Agenda 3 : Reappointment of Statutory Auditor (Sun min Kim)
  • Agenda 4 : Approval of Limit on Remuneration of Directors (USD 5,000,000)
  • Agenda 5 : Approval of Limit on Remuneration of Statutory Auditor (USD 100,000)
  • Agenda 6 : Grant of Stock Options (Jin-Hyoung Kang, Byoung Jo Kang, Gene Namgoong)
  • Agenda 7 : Approval of the grant of stock options pursuant to the Board of Directors’ resolution
Results of the 7th general meeting of shareholders

(Share present : 9,429,204 / 16,545,068 (56.99%))

Agenda Results
Agenda 1 Approval of the Financial Statements for the Financial Year 2021 Approved
Agenda 2

Agenda 2-1
Agenda 2-2
Agenda 2-3 		Reappointment of Directors

Reappointment of Independent Director: Byoung Jo Kang
Appointment of Independent Director: Jin-Hyoung Kang
Appointment of Non-Executive Director: Jung Won Woo

Approved
Approved
Approved
Agenda 3 Reappointment of Statutory Auditor (Sun min Kim) Approved
Agenda 4 Approval of Limit on Remuneration of Directors (USD 5,000,000) Approved
Agenda 5 Approval of Limit on Remuneration of Statutory Auditor (USD 100,000) Approved
Agenda 6 Grant of Stock Options (Jin-Hyoung Kang, Byoung Jo Kang, Gene Namgoong) Approved
Agenda 7 Approval of the grant of stock options pursuant to the Board of Directors’ resolution Approved

※ Shares present : Total number of the common shares with voting rights represented at the opening of the Meeting basis